medigraphic.com
ISSN 1561-3011 (Electronic)

2013, Number 3

<< Back

Rev Cubana Invest Bioméd 2013; 32 (3)

Placebo: the brightest «spot» in medicine

Rodríguez MBC, Rivas SSR

Language: Spanish
References: 50
Page: 366-378
PDF size: 267.29 Kb.


ABSTRACT

Introduction: no term has probably been as misused and has caused so much confusion as the term 'placebo'. Its effects have strengthened medical treatments throughout history without receiving due recognition. Understood as events attributable to the significance acquired by an intervention in a given therapeutic context, it takes on a new dimension, detaching from the prevailing tautological definitions.
Objective: analyze the challenges posed by this theoretical stand, as well as its potential for research and clinical practice.
Method: an analysis is conducted of the limitations of its use in randomized clinical trials, among them the efficacyparadox. A contrast is made of evidence of its effectiveness generated in various contexts. A description is provided of placebos available in clinical practice and situations of use, as well as doctors' and patients' opinions. Its effect is presented from a biopsychosocial perspective, within the framework of Lifestyle Medicine. An outline is provided of the factors preventing alternative medicines from being «better than a placebo». Finally, its place in clinical practice is identified and exemplified.
Conclusions: the placebo effect should be understood as an effect from the context, structured on the basis of the individual significance assigned to the intervention by a specific culture and historical development, which is significant for a large number of diseases, through the activation and modification of psychological and physiological variables. Conceived of as an Optimal Healing Environment, it acquires the «active principle» required to act by itself (when the alternative is doing nothing), or strengthen the effect of conventional treatments.


REFERENCES

  1. Hyland ME. The Origins of Health and Disease. Cambridge: Cambridge University Press; 2011.

  2. Jonas WB. Reframing placebo in research and practice. Phil Trans R Soc B. 2011;366:1896-904.

  3. Myers WB. The placebo as performance: speaking across domains o of healing. Qualitative Health Research. 2010;20(9):1295-303.

  4. Meissner K, Kohls N, Colloca L. Introduction to placebo effects in medicine: mechanisms and clinical implications. Phil Trans R Soc B. 2011;366:1783-9.

  5. Walach H. Placebo controls: historical, methodological and general aspects. Phil Trans R Soc B. 2011;366:1870-8.

  6. Jamshidam F, Hubbard AE, Jewel NP. Accounting for perception, placebo and unmasking effects in estimating treatment effects in randomized clinical trials. Statistical Methods in Medical Research [serial on the Internet]. en prensa: Available from: http://smm.sagepub.com/content/early/2011/09/08/0962280211413499 .

  7. Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S. The placebo response in clinical trials: more questions than answers. Phil Trans R Soc B. 2011;366:1889-95.

  8. Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Phil Trans R Soc B. 2011;366:1922-30.

  9. Colagiuri B. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity. Clinical Trials. 2010;7:246-55.

  10. Hegerl U, Mergl R. The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. Journal of Psychopharmacology. 2010;24(4):44-58.

  11. Colloca L, Miller FG. How placebo responses are formed: a learning perspective. Phil Trans R Soc B. 2011;366:1859-69.

  12. Pollo A, Carlino E, Benedetti F. Placebo mechanisms across different conditions: from the clinical setting to physical performance. Phil Trans R Soc B. 2011;366:1790-8.

  13. Linde K, Fässler M, Meissner K. Placebo interventions, placebo effects and clinical practice. Phil Trans R Soc B. 2011;366:1905-12.

  14. Vits S, Cesko E, Enck P, Hillen U, Schadendorf D, Schedlowski M. Behavioural conditioning as the mediator of placebo responses in the immune system. Phil Trans R Soc B. 2011;366:1799-807.

  15. Vase L, Næsted Nørskov K, Laue Petersen G, Price DD. Patients' direct experiences as central elements of placebo analgesia. Phil Trans R Soc B. 2011;366:1913-21.

  16. Flaten MA, Aslaksen PM, Lyby PS, Bjørkedal E. The relation of emotions to placebo responses. Phil Trans R Soc B. 2011;366:1818-27.

  17. Hyland ME. Motivation and placebos: do different mechanisms occur in different contexts? Phil Trans R Soc B. 2011;366:1828-37.

  18. Kohls N, Sauer S, Offenbächer M, Giordano J. Spirituality: an overlooked predictor of placebo effects? Phil Trans R Soc B. 2011;366:1838-48.

  19. Kaptchuk TJ. Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing. Phil Trans R Soc B. 2011;366:1849-58.

  20. Babel P. The effect of question wording in questionnaire surveys on placebo use in clinical practice. Evaluation & the Health Professions [serial on the Internet]. en prensa: Available from: http://eph.sagepub.com/content/early/2011/09/03 /0163278711420285.

  21. Justman S. From medicine to psychotherapy: the placebo effect. History of the Human Sciences. 2011;24(1):95-107.

  22. Colloca L, Finnish D. Nocebo effect, patient-clinician communication and therapeutic outcomes. JAMA. 2012;307(6):567-8.

  23. Mora MS, Nestoriuc Y, Rief W. Lessons learned from placebo groups in antidepressant trials. Phil Trans R Soc B. 2011;366:1879-88.

  24. Bishop FL, Jacobson EE, Shaw JR, Kaptchuk TJ. Scientific tools, fake treatments, or triggers for psychological healing: How clinical trial participants conceptualise placebos. Social Science & Medicine. 2012;74:767-74.

  25. van der Geest S, Hardon A. Social and cultural efficacies of medicines: Complications for antiretroviral therapy. Journal of Ethnobiology and Ethnomedicine. 2006;2:48.

  26. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003974. doi: 10.1002/14651858.CD003974.pub3.

  27. Atlas LY, Wager TD. How expectations shape pain. Neurosci Lett. 2012 Jun 29;520(2):140-8. doi: 10.1016/j.neulet.2012.03.039.

  28. Buhle JT, Stevens BL, Friedman JJ, Wager TD. Distraction and Placebo : Two Separate Routes to Pain Control. Psychological Science. 2012;23:246-53.

  29. Meissner K. The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Phil Trans R Soc B. 2011;366:180-17.

  30. Hawkins N, Scott MA. Cost-Effectiveness Analysis: Discount the Placebo at Your Peril. Medical Decision Making. 2010;30:536-43.

  31. Fässler M, Meissner K, Schneider A, Linde K. Frequency and circumstances of placebo use in clinical practice - a systematic review of empirical studies. BMC Medicine [serial on the Internet]. 2010; 8: Available from: http://www.biomedcentral.com/1741-7015/8/15 .

  32. Mora Ripoll R. Medicina del Estilo de Vida: La importancia de considerar todas las causas de la enfermedad. Revista de Psiquiatría y Salud Mental. 2012;5(1):48-52.

  33. van der Greef J, van Wietmarschen H, Schroën J, Wang M, Hankemeier T, Xu G. Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western Medicine. Planta Med. 2010;76:2036-47.

  34. Rock AJ, Permezel FE, Storm L. Randomized expectancy-enhanced placebocontrolled trial of the impact of Quantum BioEnergetic distant healing and paranormal belief on mood disturbances: a pilot study. The Journal of Science and Healing. 2012;8(2):107-17.

  35. Linde K, Nieman K, Schneider A, Meissner K. How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials. BMC Medicine [serial on the Internet]. 2010; 8: Available from: http://www.biomedcentral.com/1741- 7015/8/75 .

  36. Witt CM, Lüdtke R, Willich SN. Homeopathic treatment of patients with chronic sinusitis: A prospective observational study with 8 years follow-up. BMC Ear, Nose and Throat Disorders [serial on the Internet]. 2009; 9: Available from: http://www.biomedcentral.com/1472-6815/9/7 .

  37. Hyland ME, Geraghty AWA, Joy OET, Turner SI. Spirituality predicts outcome independently of expectancy following flower essence self-treatment. Journal of Psychosomatic Research. 2006;60:53-8.

  38. Hyland ME, Whalley B. Motivational concordance: An important mechanism in self-help therapeutic rituals involving inert (placebo) substances. Journal of Psychosomatic Research. 2008;65:405-13.

  39. Hyland ME, Whalley B, Geraghty AWA. Dispositional predictors of placebo responding: A motivational interpretation of flower essence and gratitude therapy. Journal of Psychosomatic Research. 2007;62:331-40.

  40. Ernst E. Bach flower remedies: a systematic review of randomised clinical trials. Swiss Med Wkly. 2010 Aug 24;140:w13079. doi: 10.4414/smw.2010.13079.

  41. Halberstein RA, Shirkin A, Ojeda-Vaz MM. When Less Is Better: A Comparison of Bach Flower Remedies and Homeopathy. Ann Epidemiol. 2010;20(4):298-307.

  42. Thaler K, Kaminski A, Chapman A , LangleyT, Gartlehner G. Bach Flower Remedies for psychological problems and pain: a systematic review. BMC Complement Altern Med. 2009;9(16): 45-55.

  43. Walach H, Rilling C, Engelke U. Efficacy of Bach-flower remedies in test anxiety: A double-blind, placebo-controlled, randomized trial with partial crossover. J Anxiety Disord. 2001;15(4):359-66.

  44. Rodríguez-Martín BC. El Sistema Diagnóstico-Terapéutico de Edward Bach: apuntes para una sistematización necesaria. Hereford: Twelve Healers Trust; 2009.

  45. Monvoisin R. Élixirs floraux de Bach : Critique des concepts pseudo-scientifiques, pseudo-médicaux et des postures philosophiques induites par la théorie du Dr Bach. Ann Pharm Fr. 2005;63:416-28.

  46. Whalley B, Hyland ME. One size does not fit all: Motivational predictors of contextual benefits of therapy. Psychology and Psychotherapy: Theory, Research and Practice. 2009;82:291-303.

  47. Wheeler P, Hyland ME. The development of a scale to measure the experience of spiritual connection and the correlation between this experience and values. Spirituality and Health International. 2008;9:193-217.

  48. Bach E. Twelve Healers & Other Remedies. In: Barnard J, editor. Colleted Writings of Edward Bach. Hereford: Flower Remedy Programme; 1987. p. 34-49.

  49. Rodríguez-Martín BC, Rodríguez-Méndez L. Esencias florales, efecto placebo y psicoterapia. In: GC-Bach, editor. Cuadernos de Investigación II. Hacia una práctica basada en la evidencia. Santa Clara: Feijóo; 2010. p. 7-29.

  50. Piqueras Rodríguez JA, Ramos Linares V, Martínez González AE, Oblitas Guadalupe LA. Emociones negativas y su impacto en la salud mental y física. Suma Psicológica. 2009;16(2):85-112.




2020     |     www.medigraphic.com